Moschovakis Capital publishes institutional-grade equity research on companies we believe are trading below intrinsic value. Every thesis follows our proprietary framework: business fundamentals, valuation discipline, management quality, and strict risk control. These are not stock tips. This is deep fundamental analysis designed for serious capital allocators.
Follow the Research With Real Capital
Every thesis below is backed by real capital. Angelos Moschovakis is a verified eToro Popular Investor — copy the full equity portfolio and access these positions automatically.
New to eToro? Open an account here and start copying.
eToro is a multi-asset platform. The value of your investments may go up or down. Your capital is at risk. Copy trading does not amount to investment advice. Past performance is not an indication of future results.
Get the Research Delivered
Institutional equity research. Delivered free to your inbox when we publish. No spam. No hype. Just analysis.
EXE Stock Analysis: 49% Upside Case for 2026 – Institutional Research Note
Expand Energy Corporation (NASDAQ: EXE) presents one of the more nuanced EXE stock analysis opportunities in the North American natural gas sector today. As the
MSCI Stock Analysis: 23% Upside Case for 2026 – Institutional Research Note
MSCI stock analysis is the starting point for any serious investor evaluating the financial data infrastructure sector. MSCI Inc. (NYSE: MSCI) occupies one of the
EssilorLuxottica Stock Analysis: 20% Upside Case for 2026 – Institutional Research Note
This EssilorLuxottica stock analysis examines whether the world’s dominant eyewear monopoly deserves a place in a wealth preservation portfolio at current prices. EssilorLuxottica (EL.PA) trades
JPMorgan Stock Analysis: 9.8% CAGR Upside Case for 2026 – Institutional Research Note
Executive Summary — Bottom Line Up Front This JPMorgan stock analysis assigns a BUY recommendation with a base case fair value of $365, representing 16%
NICE Stock Analysis: 79% Upside Case for 2026 – Institutional Research Note
Executive Summary — Bottom Line Up Front This NICE stock analysis identifies one of the most compelling asymmetric risk/reward setups in enterprise software today. NICE
BROS Analysis: 18% Projected CAGR Upside for 2026 – Institutional Research Note
This Dutch Bros stock analysis examines one of the most compelling unit-growth stories in the U.S. quick-service restaurant sector — and why our Wealth Preservation
Venture Global Stock Analysis: 5 Critical Risks Exposed for 2026 – Institutional Research Note
Executive Summary: Venture Global Stock Analysis This institutional equity research delivers a definitive verdict on NYSE: VG — and the conclusion is unambiguous. BOTTOM LINE
SEIC Stock Analysis: 30% Upside Case for 2026 – Institutional Research Note
This SEIC stock analysis examines why SEI Investments Company (NASDAQ: SEIC) presents one of the most compelling asymmetric opportunities in financial technology for capital allocators
Tripadvisor Stock Analysis: 7 Reasons We Rate TRIP “Avoid” in 2026 – Institutional Research Note
Our Tripadvisor stock analysis assigns a Wealth Preservation Score of just 25/100 — a decisive AVOID rating under the Moschovakis Capital framework. At a current